Joshua Cohen is an independent healthcare analyst. The focus of his work is pricing and reimbursement of biopharmaceuticals and diagnostics.
Current projects include:
– Incorporation of patient-centric outcomes in value frameworks, such as ICER
– Pricing and reimbursement of orphan and cancer drugs
– Sustainability of future healthcare spending/funding
– Patient adherence to single versus multi-tablet regimens of HIV medicines
– Pricing of Covid-19 treatments and coronavirus vaccines